Cannabix Technologies Logo
CA13765L1013

Cannabix Technologies

Ins Portfolio

Kurse werden geladen...

 Anzeige

Prognose

Für dieses Unternehmen liegen uns keine Analysten-Daten vor.

Scoring-Modelle

Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.

News

  • Foto von Cannabix and AlcoPro Enter MOU for Marijuana Breathalyzer Marketing

    Cannabix and AlcoPro Enter MOU for Marijuana Breathalyzer Marketing

    VANCOUVER, British Columbia, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) developer of marijuana and alcohol breath testing devices is pleased to report that it has entered a memorandum of understanding (“MOU”) with AlcoPro Inc. (“AlcoPro”) of Knoxville, TN, to begin collaborating on marketing efforts for the Cannabix Marijuana Breathalyzer (“CMB”) technology in the United States. In the short-term, AlcoPro will include the CMB hardware in its upcoming 2025 product catalogue, mailed to over 70,000 businesses in U.S. and globally. AlcoPro is a well-established distributor and leading supplier of drug and alcohol testing instruments, kits, and supplies for professional use, since 1982.» Mehr auf globenewswire.com

  • Foto von Cannabix Technologies Announces Key Hardware Advancements to Marijuana Breathalyzer Technology

    Cannabix Technologies Announces Key Hardware Advancements to Marijuana Breathalyzer Technology

    VANCOUVER, British Columbia, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) developer of marijuana and alcohol breath testing devices is pleased to report that it has made significant updates to its Cannabix Marijuana Breathalyzer (“CMB”) technology to meet suggested emerging regulatory requirements in preparation for marketing. Cannabix engineers have incorporated several new features to the Company's Breath Collection Unit (“BCU”) – a critical hardware tool used for portable collection of delta-9 THC in breath (images below). These developments come as the need for marijuana breath detection gains intensity in the United States and globally.» Mehr auf globenewswire.com

  • Foto von Cannabix Technologies Receives Positive Testing Certification for Breath Logix Autonomous Alcohol Breathalyzer

    Cannabix Technologies Receives Positive Testing Certification for Breath Logix Autonomous Alcohol Breathalyzer

    Cannabix has developed an autonomous alcohol breathalyzer screening device for employers and a range of industries and safety settings Cannabix has developed an autonomous alcohol breathalyzer screening device for employers and a range of industries and safety settings» Mehr auf globenewswire.com

Unternehmenszahlen

Im letzten Quartal hatte Cannabix Technologies einen Umsatz von 0,00 und ein Nettoeinkommen von 296,69k
(EUR)Okt. 2024
YOY
Umsatz0,00-
Bruttoeinkommen0,00100,00%
Nettoeinkommen296,69k52,68%
EBITDA265,73k58,79%

Fundamentaldaten

MetrikWert
Marktkapitalisierung
+41,39 Mio
Anzahl Aktien
115,14 Mio
52 Wochen-Hoch/Tief
+0,37 - +0,33
DividendenNein
Beta
2,23
KGV (PE Ratio)
17,29
KGWV (PEG Ratio)
0,71
KBV (PB Ratio)
+16,55
KUV (PS Ratio)
0,00

Unternehmensprofil

Cannabix Technologies Inc. ist ein Technologieunternehmen, das Marihuana-Atemtests für Arbeitgeber, Strafverfolgungsbehörden, Regierungen und die Öffentlichkeit in Nordamerika entwickelt. Es entwickelt Tetrahydrocannabinol-Atemtests, ein Instrument zur schnellen Erkennung des jüngsten Cannabiskonsums, sowie Atemsammelgeräte. Das Unternehmen war früher als West Point Resources Inc. bekannt und änderte im August 2014 seinen Namen in Cannabix Technologies Inc. um. Cannabix Technologies Inc. wurde im Jahr 2011 gegründet und hat seinen Sitz in Burnaby, Kanada.

Name
Cannabix Technologies
CEO
Ravinder S. Mlait B.A., BA, M.B.A., MBA
SitzBurnaby, bc
Kanada
Website
Börsengang
Mitarbeiter0

Ticker Symbole

BörseSymbol
Pnk
BLOZF
Cnq
BLO.CN
Frankfurt
8CT.F
London
0UO6.L
München
8CT.MU
Düsseldorf
8CT.DU
🍪

Parqet nutzt Cookies.Erfahre Mehr